Danish Headache Center: Migraine Disorders trials

The registry lists 60 Migraine Disorders studies with Danish Headache Center as lead sponsor. 9 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 2Phase 4 3No phase 55(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Selective Activation of the Adrenomedullin Receptors in MigraineRecruitingNCT07451769Not applicable
• Induction of Migraine Attacks With Aura Using Pituitary Adenylate Cyclase Activating Polypeptide-38Not yet recruitingNCT07342296Not applicable
• Amylin-Induced Migraine Attacks Without AuraNot yet recruitingNCT07340788Not applicable
• Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related PeptideRecruitingNCT07021859Not applicable
• Substance P-Induced Migraine Attacks Without AuraRecruitingNCT06959004Not applicable
• Muscle Function and Tenderness Differences in Headache PatientsEnrolling by invitationNCT06859463
• Investigation of Functional Brain Features in Women with MigraineRecruitingNCT06470958
• Registry for Migraine - Structural and Functional MRI Before and After Erenumab TreatmentRecruitingNCT04674020Phase 4
• Hypersensitivity to CGRP as a Predictive Biomarker of Migraine Prevention With ErenumabRecruitingNCT04592952Phase 4
• Muscle Function and Strength Training of the Neck and Shoulder in Migraine and Tension-type Headache Patients. A Singel Arm Open Label TrialActive, not recruitingNCT06112587Not applicable
• Effect of Sildenafil in Individuals With Migraine Pretreated With ErenumabCompletedNCT05889455Not applicable
• Effect of Levcromakalim in Individuals With Migraine Pretreated With ErenumabCompletedNCT05889442Not applicable
• Effect of Riocigaut on Migraine Attack Induction in People With MigraineCompletedNCT05750446Not applicable
• Migraine Induction Properties of PACAP-38 After Eptinezumab in Migraine Without Aura Patients.CompletedNCT05635604Not applicable
• The Involvement of ATP Sensitive Potassium Channel in Migraine Aura and Migraine Pain.Status unknownNCT05565001Not applicable
• Examination of Muscle Stiffness, Tenderness and Pressure Pain Thresholds During a Cycle of Botulinum Toxin A Treatment in Chronic Migraine PatientsCompletedNCT05328687
• Improved Treatment Course for Patients With Migraine and Tension-type HeadacheCompletedNCT05278325Not applicable
• Effect of Sumatriptan on Levcromakalim-Induced Symptoms in Individuals With MigraineCompletedNCT05211050Not applicable
• Migraine Inducing Effect of Levcromakalim in Patients With Migraine With AuraCompletedNCT04905654Not applicable
• Headache Inducing Effect of NN414 in Migraine PatientsStatus unknownNCT04744129Not applicable
• Registry for Migraine - Clinical CoreStatus unknownNCT04603976Phase 4
• The Effect of Adenosine on Cranial Hemodynamic, Headache and Migraine Induction Properties.CompletedNCT04577443Not applicable
• The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine PatientsStatus unknownNCT04452929Not applicable
• The Effects of a Long-lasting Infusion of Vasoactive Intestinal Peptide (VIP) in Episodic Migraine PatientsCompletedNCT04260035Not applicable
• Investigation of Vasodilation and Intensity of Headache Triggered by Glucagon Like Peptide-1 in HumansStatus unknownNCT04232605Not applicable
• Adrenomedullin Effect on Migraine Without PatientsCompletedNCT04111484Not applicable
• Headache Inducing Effect of Levcromakalim in Migraine With Aura PatientsCompletedNCT04012047Not applicable
• The Effects of Maxipost (BMS 204352) on Cerebral Hemodynamic and Headache in Healthy Volunteers and Migraine PatientsCompletedNCT03887325Not applicable
• PACAP38 Induced Headache, Migraine and Flushing in Patients With MigraineCompletedNCT03881644Not applicable
• Deep Phenotyping of Rosacea and MigraineCompletedNCT03872050
• Day to Day Variation of Pressure Pain Threshold and Muscle HardnessCompletedNCT03632928
• Muscle Tenderness and Hardness in Migraine PatientsCompletedNCT03626805
• Amylin and CGRP Head to Head Provocation in Migraine Without Aura PatientsCompletedNCT03598075Not applicable
• The Effect of PACAP27 on the Extra- and Intracerebral Arteries Assessed by Magnetic Resonance Angiography (MRA) on Healthy VolunteersCompletedNCT03560024Not applicable
• CGRP-induced Migraine Attacks in Patients Who Have Tried Anti-CGRP Monoclonal Antibody TreatmentStatus unknownNCT03481400Not applicable
• PACAP27 Headache Properties in Migraine Without Aura PatientsCompletedNCT03471039Not applicable
• Headache Inducing Effect of Cromakalim in Migraine PatientsCompletedNCT03228355Not applicable
• Pretreatment With Sumatriptan on Cilostazol Induced Headache in Healthy VolunteersCompletedNCT03156920Not applicable
• Pharmacologically Triggered Migraine Without Aura and NeuroimagingStatus unknownNCT03143465Not applicable
• Carbon Monoxide Migraine-inducing Effects in Patients With Migraine Without Aura.CompletedNCT03075020Not applicable
• Investigation of Vascular Inflammation in Migraine Using Molecular Nano-imaging and Black Blood Imaging MRICompletedNCT02549898Not applicable
• Physiological Changes With SPG Stimulation in Migraine PatientsCompletedNCT02510742Not applicable
• The Effect of Sumatriptan and Placebo on Cilostazol Induced HeadacheCompletedNCT02486276Not applicable
• The Effect of Sumatriptan and Placebo on Isosorbide-5-mononitrate Induced HeadacheCompletedNCT02485340Not applicable
• Transcriptomic and Biochemical Changes During a Migraine AttackCompletedNCT02468622
• Investigation of Serotonin Receptor Binding in the Migraine Brain Using Positron Emission TomographyCompletedNCT02309606
• Exercise in Migraine and Co-existing Tension-type Headache and Neck PainCompletedNCT02269501Not applicable
• PACAP Induced Migraine Attacks in Patients With High and Low Genetic LoadCompletedNCT02158221Not applicable
• CGRP Induced Migraine Attacks in Patients With High and Low Genetic LoadCompletedNCT01924052Not applicable
• Migraine With Aura Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow by HypoxiaCompletedNCT01896167Not applicable
• The Headache Inducing Effects of Cilostazol on Migraine PatientsCompletedNCT01841827Not applicable
• EP4-receptor Antagonism and Prostaglandin E2 (PGE2) in a Human Headache ModelCompletedNCT00957983Phase 1/2
• Study of the Safety and Effectiveness of NXN-188 for the Acute Treatment of Migraine Attacks With AuraStatus unknownNCT00877838Phase 2
• Calcitonin Gene-related Peptide in Familial Hemiplegic Migraine (FHM) and Migraine With Aura (MA)CompletedNCT00687947Not applicable
• Glyceryl-Trinitrate-Induced Headache in Patients With Familial Hemiplegic MigraineCompletedNCT00541736Not applicable
• PACAP38´s (Pituitary Adenylate Cyclase-Activating Polypeptide) Headache Inducing Characteristics and Effects on the Cerebral Blood FlowCompletedNCT00380263Not applicable
• Functional MRI (fMRI) in CGRP Induced MigraineCompletedNCT00363532Not applicable
• Calcitonin Gene Related Peptide-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2.CompletedNCT00358839Not applicable
• Glyceryl-Trinitrate-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2CompletedNCT00257985Not applicable
• Experimental Headache Induced by Vasoactive Intestinal PolypeptideCompletedNCT00255320Not applicable